Comparison of the soluble fms-like tyrosine kinase 1/ placental growth factor-ratio alone versus a multi-marker regression model for the prediction of preeclampsia-related adverse outcomes after 34 weeks of gestation

Conclusions: Integrating angiogenic biomarkers in a regression model improved the prediction of preeclampsia-related adverse outcomes in women at risk after 34 weeks of gest ation.
Source: Fetal Diagnosis and Therapy - Category: Perinatology & Neonatology Source Type: research